Table 1.
Simulated systema | Number of simulations × length [μs] |
---|---|
2n0j_wt | 1 × 10 μsb, 5 × 1 μs |
2n0j_RIO_wt | 1 × 10 μsb, 3 × 1 μs |
2n0j_RIO_wt_CaseP_OPCc | 1 × 1 μs |
2n0j_RIO_wt_HBfix_Ad | 1 × 1 μs |
2n0j_RIO_wt_HBfix_Bd | 3 × 1 μs |
2n0j_RIO_wt_HBfix_Cd | 1 × 1 μs |
2n0j_C14+ | 1 × 10 μsb, 5 × 1 μs |
2n0j_RIO_C14+ | 1 × 10 μsb, 3 × 1 μs |
2n0j_RIO_wt_Nae | 4 × 1 μs |
free_RIOf | 1 × 1 μs |
1bvjg | 1 × 1 μs |
3rg5g | 1 × 0.5 μs |
aThe abbreviations ‘wt’, ‘C14+’, and ‘RIO’ in the simulation names refer to systems containing the wild-type uracil 14, protonated cytosine 14, and the ribostamycin ligand, respectively.
bOnly the first microsecond of the ten-microsecond simulations, along with all the one-microsecond simulations, is included in the analyses presented in the main text. The rest of the ten-microsecond simulations (i.e. time interval of 1–10 μs) is described in the Supplementary Data.
dThe U14(O2′)/A16(N7) H-bond interaction was stabilized using 1 kcal/mol (variant A) or 2 kcal/mol (variant B) HBfix potential function (61). In variant C, we used 1 kcal/mol repulsive HBfix potential to destabilize the spurious U14(O2′)/U15(O5′) interaction, in addition to the HBfix potential used in variant A. All HBfix potentials were applied in the 2–3 Å hydrogen-acceptor distance range (61).
eNa+ ions were used instead of K+.
fSimulation of a free ribostamycin.